Danaher buys Masimo for $180 per share. Explore the details of this $9.9B healthcare acquisition and its impact on medical technology. Get the facts!

The firm initiated a new position by purchasing about 1.6 million shares. It position equals 15.3% of the fund’s 13F assets under management. Initiated a new position valued at about $203 million ...

Masimo shares rocketed after biotech conglomerate Danaher struck a deal to acquire the medical-device maker for almost $10 billion. Masimo shares (MASI) surged by roughly one-third Tuesday morning to ...

Irvine-based Masimo is being acquired by Danaher Corp. in a deal with an enterprise value of about $9.9 billion, allowing it to gain a foothold in the medical supply business. Danaher will pay $180 ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The deal is expected to close in ...

Danaher Corp. agreed to buy Masimo Corp., in a deal with an enterprise value of about $9.9 billion, allowing it to gain a foothold in the medical supply business. Danaher will pay $180 per share in ...

Danaher will acquire pulse oximeter maker Masimo in a $9.9 billion deal, as the life science firm looks to bulk up its diagnostics portfolio. The companies said on Tuesday that Danaher will pay $180 ...

A U.S. jury ruled on November 15, 2025, that Apple must pay Masimo $634 million in a patent infringement case over smartwatch technology, awarding Masimo a major victory after years of litigation.

Medical technology company Masimo (MASI) has agreed to be acquired by Danaher Corporation (DHR) for $180 per share in cash, valuing the deal at approximately $9.9 billion. California-based Masimo's ...

Feb 17 (Reuters) - Danaher (DHR.N), opens new tab, a $150 billion U.S. company that makes tools used in developing and testing medicines, on Tuesday agreed to buy Masimo (MASI.O), opens new tab for $9 ...